Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
10.06%
SONIC FOUNDR SOFO
8.21%
NOAH HOLDING NOAH
5.27%
TRI TECH HOL TRIT
5.15%
FLOWERS FOOD FLO
4.46%
 

TODAY'S TOPICS

1. ZACKS RANK BUY STOCKS: Today we highlight four new stocks: Perrigo (PRGO), Flowserve (FLS), Nvidia (NVDA) and Perini (PCR). Get these stories below.

2. BEST OF EQUITY RESEARCH: Eighteen members of the S&P 500 will report this week, including ADBE, BBY, DFS, MS and ORCL. Read the Earnings Preview and get our Bull and Bear Stocks of the Day.

3. STRATEGIES & IDEAS: Find true bargains with the High Rank Value profit track.

4. ZACKS EXTRA: Simulator player "RebelPOW" blogs about moving average crossovers, and uses RL as an example.

Read current and past issues of this newsletter.

 

Analysts' Brain Cramp Could Set Up Your Big-Time Payoff

This is that BIG... maybe bigger... one small company has electrified the cancer treatment community with a device that destroys common cancer tumors. No one else sells a device like it - one that can blast prostate tumors, evaporate lung tumors and ablate breast tumors. Better still for you, the company's stock seems totally mispriced and it is blessed with the potential to quickly double your money, and that's just for a start.

Find out more now.
 

Monday - December 17, 2007

1. ZACKS RANK BUY STOCKS

Zacks #1 Rank stocks average a 32% annual return. Every day on Zacks.com we highlight four new Zacks Rank Buy stocks based on the four main schools of investing: Aggressive Growth, Momentum, Growth & Income and Value.

 
Aggressive Growth - Perrigo Company (PRGO)

Perrigo Company (PRGO) just received some great news from the FDA about a heartburn drug. That gave the shares a nice boost. The company also reported excellent fiscal first-quarter earnings. Read the full analysis on PRGO now!

 
Growth & Income - Flowserve Corp. (FLS)

Flowserve Corp. (FLS) declared a dividend of 15 cents per share in mid-November and is yielding about 0.7%. FLS, which recently hit fresh 52-week high, offers a ROE of 17%. Read the full analysis on FLS now!

 
Momentum - Nvidia Corporation (NVDA)

Nvidia Corporation (NVDA) recently reported an excellent quarter that saw its earnings more than double. In addition, almost every single covering analyst has increased expectations. Read the full analysis on NVDA now!

 
Value - Perini Corp. (PCR)

Perini Corp. (PCR) is a cheap stock with excellent fundamentals. PCR has posted an average surprise of 63.9% over the past four quarters. Read the full analysis on PCR now!

 

 
OTHER ZACKS RANK RESOURCES

  • Zacks Rank Home Page: Go there now.
     
  • All Zacks #1 Rank Stocks Learn more...
     
  • Zacks/Schaeffer's Options Trader: Gain the 1-2 punch of the powerful Zacks Rank and Bernie Schaeffer's proven option trading expertise for market-beating profits. Learn more...
     
  • Zacks Momentum Trader: Get buy alerts for stocks that are ready to explode. Pinpoint the right stock at the right time with less volatility than the S&P 500. Learn more...

2. BEST OF EQUITY RESEARCH

Back to top

The Zacks Equity Research team of 50 analysts generates a mountain of timely research every day that is geared towards long term stock investing. Here we turn the spotlight on some of their hottest insights.
 

EARNINGS PREVIEW for Dec 17 - Dec 21 with Charles Rotblut

Eighteen members of the S&P 500 will report this week, including ADBE, BBY, DFS, MS and ORCL. More...

 
ANALYST BLOG

Stocks featured recently include Wyeth (WYE), Stone Energy (SGY), Wright Medical (WMGI) and URS Corp. (URS). To see the latest analyst posts,  click here.

 
BULL OF THE DAY

Core Labs (CLB) - Premium Justified. For the full Zacks research report, click here.

 
BEAR OF THE DAY

Amylin Pharma (AMLN) - Not Worth Risk. For the full Zacks research report, click here.

 
ZACKS ANALYST INTERVIEW

M&A Keeps Fixed-Line Carriers Up

We continue to witness industry consolidation and private equity deals creating higher stock valuations. More...

 
ZACKS INDUSTRY RANK with Charles Rotblut

Visibility Good for Tech, Bad for Brokers

Learn why storage device maker WDC is optimistic. Plus, get a preview of fourth-quarter earnings for LEH, GS, MS and BSC. More...

 
EARNINGS TRENDS with Dirk Van Dijk

Financials Fall

Analysts are relentlessly cutting their estimates for the financial sector. More...

 

 
OTHER ZACKS EQUITY RESEARCH RESOURCES

  • Zacks Equity Research Home Page: Go there now.
     
  • All Rating Upgrades Learn more...
     
  • Zacks Elite narrows down Zacks Equity Research recommendations into three focused portfolios. Learn more...
     
  • Zacks Top 10 Stocks for 2008: Buy 'em. Do nothing. Beat the market. (Up 33% in 2007). Learn more...
     

3. STRATEGIES & IDEAS

Back to top

Here you will find fresh articles loaded with profitable investment strategies and ideas to help you beat the market. Today we highlight...

 
PROFIT TRACKS: HIGH RANK VALUE

This strategy shows investors how to screen for value stocks that are expected to improve in the future. Four stocks meeting this screen's exclusive criteria include TMP, BMO, CM and SLF. More...

 
INVESTMENT IDEAS

Fast Food, Fat Profits

Investors are cashing in on the much maligned fast food sector. Stocks highlighted include MCD, BKC, JBX and THI. More...

 
SCREEN OF THE WEEK

Diversification and Portfolio Weighting

Kevin Matras talks about diversification and the importance of an equally dollar weighted portfolio. Stocks mentioned include CASY, CY and LEA. More...

 
ZACKS WEALTH MANAGEMENT

Protecting Your Assets from Creditors

The more accessible the asset is, the greater the risk that a creditor will have claim on it. More...

 
FREE REPORT: Top 10 Stock Picking Strategies

Most of the strategies highlighted in the articles above were created using the Zacks Research Wizard screening and backtesting software. Learn more about this powerful tool and get your free copy of our special report "Top 10 Stock Screening Strategies". More...


4. ZACKS EXTRA

Back to top

 
BEST OF ZACKS CHALLENGE BLOG

RebelPOW

FUN WITH MOVING AVERAGE CROSSOVERS (RL)
Yesterday's blog article, "Revision Moments" introduced the concept of 50-day moving averages crossing over the 200-dayas a way to find those moments in time when a stock is beginning a new move up. To give you a sample, let's consider Polo Ralph Lauren (RL). More...

 
Java J

>> JAVA'S MARKET MUSINGS #200 <<
I continue to believe the large negative expansion -bars formed on Tuesday on the daily charts of the indices are bearish, and caution is prudent in the current market environment. More...

 
Read all the Player Blog posts.

 

 
TOP ZACKS CHALLENGE PLAYER INTERVIEW: TheUncle

TheUncle" looks for stocks with a high return on equity, consistent earnings growth and a low forward price-to-earnings ratio. Read the full article.

Zacks $100,000 Challenge home.

 

 
MITCH ON THE MARKETS

Santa Claus Coming to Town? (AUDIO)

Mitch Zacks, Portfolio Manager at Zacks Investment Management, remains optimistic at prospects for a Santa Claus rally in stocks. Listen to his audio here.

Click here for more Zacks audio.

 

 
OPTIONS

McDonald's (MCD)

The put/call open interest ratio filter takes a look at this fast-food giant. More...

Options homepage: Go there now.


 
Want to own ALL the Zacks #1 Rank Stocks?

Mitch Zacks manages an exclusive portfolio for his private clients based on the Zacks #1 Rank Model. From 2002 through 09/30/07, this portfolio has outperformed the S&P 500 by a staggering 60.8%! Learn more in Your FREE Investment KIT that outlines Mitch's complete track record along with details on his time tested philosophy.

Get Your FREE ZACKS INVESTMENT KIT.
 


 

 
OTHER POPULAR FEATURES FROM ZACKS

 

 
Manage your Profit from the Pros subscription:

 
REFER-A-FRIEND

If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS! http://at.zacks.com/?id=2311

Regards and Happy Investing,

Charles Rotblut, CFA
Senior Market Analyst
Zacks.com

p.s. What is the mission for Zacks Profit from the Pros? Click here to find out how we will help you become a more successful investor.


The performance of the Zacks Rank portfolios shown above for annual and year-to-date periods are the linked monthly total returns (price changes + dividends) of equal weighted hypothetical portfolios, consisting of those stocks with the indicated Zacks Rank, assuming monthly rebalancing and zero transaction costs. These are not the returns of actual portfolios. The hypothetical portfolios were created at the beginning of each month from Jan 1988 forward based on the values of the Zacks Rank available to Zacks' clients before the beginning of each month. The portfolios created monthly from 1988 through September 2006 exclude ADRS and are comprised of stocks that have the indicated Zacks Rank and were covered by at least two analysts at the time of the stocks inclusion in the portfolio. Starting in October 2006 and going forward, the portfolios are comprised of all stocks with the indicated Zacks Rank and do not exclude ADRs, which is more reflective of the list of stocks that customers will find on the Zacks web sites. 2007 returns are for the period of Jan 1 - Jun 30, 2007. These performance numbers have been audited from 1995 through 2003 by Autschuler Melovan, a division of American Express Financial.

The S&P 500 Index is a well-known, unmanaged index of the prices of 500 large-company common stocks, mainly blue-chip stocks, selected by Standard & Poor's. The S&P 500 Index assumes reinvestment of dividends but does not reflect advisory fees. An investor cannot invest directly in an index.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

To contact us by mail:

Zacks Investment Research
Attn: Profit from the Pros
111 N. Canal St., Suite 1101
Chicago, IL 60606

To unsubscribe from receiving "Profit from the Pros" e-mail newsletter, click here.


 

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.